| Charles Edward Fortenberry, RN | |
|
1103 16th Ave Se, Decatur, AL 35601-3595 | |
| (256) 350-0362 | |
| Not Available |
| Full Name | Charles Edward Fortenberry |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 1103 16th Ave Se, Decatur, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023234648 | NPI | - | NPPES |
| 51006076 | Other | AL | BLUE CROSS BLUE SHIELD AL |
| 891017506 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 1-049601 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Edward Fortenberry, RN 1103 16th Ave Se, Decatur, AL 35601-3595 Ph: () - | Charles Edward Fortenberry, RN 1103 16th Ave Se, Decatur, AL 35601-3595 Ph: (256) 350-0362 |
News Archive
Phytel today launched the next generation of automated care management solutions with its integrated Atmosphere™ platform, which enables providers to better manage quality and proactively improve chronic and preventive care across their populations. These scalable, Software-as-a-Service automation tools together comprise the first comprehensive, integrated population health management solution designed for providers.
In June 2012, a 60 year-old man with flu-like symptoms walked into a private hospital in Jeddah, Saudi Arabia. Two weeks later, he died from multiple organ failure, becoming the first victim of a mysterious virus that came to be known as Middle East Respiratory Syndrome or MERS.
Scientists studying how genetics impact brain disease have long sought a better experimental model. Cultures of genetically-modified cell lines can reveal some clues to how certain genes influence the development of psychiatric disorders and brain cancers.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the U.S. Food and Drug Administration has granted marketing approval of the Abbreviated New Drug Application for enoxaparin sodium for injection filed by Sandoz. Developed under a collaboration agreement between Momenta and Sandoz, this product has been designated therapeutically equivalent to the reference-listed drug, Lovenox, which is marketed by Sanofi-Aventis.
› Verified 7 days ago
Mrs. Natalie Mccay, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2941 Point Mallard Pkwy Se, Suite N, Decatur, AL 35603 Phone: 256-432-2822 Fax: 256-432-2825 | |
Heather R Carter, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1350 14th Ave Se, Decatur, AL 35601 Phone: 256-355-6911 | |
Mrs. Kami Elizabeth Whorton, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1874 Beltline Rd Sw, Decatur, AL 35601 Phone: 256-301-3207 | |
Ranjanben B Patel, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1310 14th Ave Se, Decatur, AL 35601 Phone: 256-705-4224 Fax: 256-705-4135 | |
Megan Lynn Sanford, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2422 Danville Rd Sw Ste E, Decatur, AL 35603 Phone: 256-355-9040 Fax: 256-355-9048 | |
Kimberly Lee Randolph, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2205 Beltline Rd Sw, Decatur, AL 35601 Phone: 256-306-4000 |